2019-08-15T02:22:49-05:00 2018-09-30 ERNST & YOUNG US LLP TWO NORTH CENTRAL AVE STE 2300 PHOENIX AZ 85004 990 2017-10-01 331092191 THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION % KEVIN GROFF TRAN 6023438411 445 N 5TH STREET Suite 120 PHOENIX AZ 85004 MANUEL ESTRADA CFO, TGEN 6023438478 2019-08-14 true PATRICK SHIELDS P01508556 6023223000 70.162.82.4 86597020192275000000 2019-08-15 P CC069D8BE90350A9B9CF3129E95BF97A241EA1E6 6C9B1A35775087DBDB8A6D25ECA509C7F6C27838 2017 2019-02-21 02:37:17Z ERIN MASSEY 445 N 5TH STREET 120 PHOENIX AZ 85004 5440855 false X www.helptgen.org X 2004 AZ BIOGENOMIC MEDICAL RESEARCH FUNDRAISING FOR THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE (TGEN). 23 19 0 45 0 0 8383173 5436735 0 0 1763 4120 0 0 8384936 5440855 3532132 5924869 0 0 684633 980655 0 0 1313965 512417 672750 4729182 7578274 3655754 -2137419 25579679 24428539 7347261 8328582 18232418 16099957 X BIOGENOMIC MEDICAL RESEARCH FUNDRAISING FOR THE TRANSLATIONAL, GENOMICS RESEARCH INSTITUTE (TGEN). false false 5924869 5924869 0 SEE SCHEDULE O 5924869 true true false false false false false false false true false false false false false true false true false false false false false false false false false true false true false false false false false false false false false false false false false true false false false true X 5 0 true 0 false false false false false true true false false false false false X 23 19 true false false false true true true true true false false true true true true true true false false false AZ X KEVIN GROFF 6023438478 445 N 5TH STREET SUITE 600 PHOENIX AZ 85004 X Michael Bassoff Pres., Tgen Fdn (thru 4/30/18) 24.0 16.0 X X 0 531296 10306 Bennett Dorrance Board Member/Chairman 1.0 1.0 X X 0 0 0 Richard J Lehmann Board Member/Treasurer 1.0 0.0 X X 0 0 0 Ken Kendrick Board Member/Secretary 1.0 0.0 X X 0 0 0 Teresa Burleson Board Member/ASST SEC/ASST TRE 1.0 0.0 X 0 526688 21374 Karl Eller Board Member 1.0 0.0 X 0 0 0 Phil Francis Board Member 1.0 0.0 X 0 0 0 Steve Hilton Board Member 1.0 0.0 X 0 0 0 Carrie Hulburd Board Member 1.0 0.0 X 0 0 0 Mike Ingram Board Member 1.0 0.0 X 0 0 0 Catherine IVY Board Member 1.0 0.0 X 0 0 0 Michael Kaplan Board Member 1.0 0.0 X 0 0 0 David Lane Board Member 1.0 0.0 X 0 0 0 Terry Lee Board Member 1.0 0.0 X 0 0 0 Randy May Board Member 1.0 0.0 X 0 0 0 Arte Moreno Board Member 1.0 0.0 X 0 0 0 Bill Pope Board Member 1.0 0.0 X 0 0 0 William J Post Board Member 1.0 0.0 X 0 0 0 J Danforth Quayle Board Member 1.0 0.0 X 0 0 0 Troy Richards Board Member 1.0 0.0 X 0 0 0 Steve Stagner Board Member 1.0 0.0 X 0 0 0 Ray Thurston Board Member 1.0 0.0 X 0 0 0 Jeffry M Trent PhD Board Member 1.0 39.0 X 0 1019398 50386 Howard Young Board Member 1.0 0.0 X 0 0 0 Manuel Estrada Chief Financial Officer 1.0 39.0 X 0 320061 10980 Nadia Philips Vice President 40.0 0.0 X 0 125328 756 Thomas Issacs Vice President 40.0 0.0 X 0 117111 9026 0 2639882 102828 0 false true false 0 5436735 2400 5436735 0 4120 0 0 4120 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5440855 0 0 4120 X 5924869 5924869 0 0 0 531296 53130 478166 0 383332 38333 344999 0 66027 66027 0 0 0 0 0 0 0 123639 0 123639 0 52704 5270 47434 197567 19757 177810 6135 613 5522 0 98031 9803 88228 59844 5984 53860 0 131051 13105 117946 0 0 0 0 DUES & SUBSCRIPTIONS 3637 0 3637 0 RECRUITMENT 107 0 107 0 BANK FEES 35 0 35 0 7578274 5924869 339440 1313965 0 44145 942514 13797322 14778640 11653447 8696296 1225 613 0 0 0 0 0 0 0 0 23540 10476 0 0 0 0 0 0 0 0 0 0 0 0 60000 0 25579679 24428539 7347254 8179348 0 0 7 149234 0 0 0 0 0 0 0 0 0 0 0 0 7347261 8328582 X -6267703 -7277741 24438028 23239772 62093 137926 18232418 16099957 25579679 24428539 -2137419 4958 X false true X true false X 13561515 9117401 5831237 8383173 5436735 42330061 0 0 13561515 9117401 5831237 8383173 5436735 42330061 10161055 32169006 1004 1005 0 1763 4120 7892 0 0 42337953 0.75982 0.76368 X SCHEDULE A, PART III The columns in Schedule A, Part II correspond to the following periods: Column (E) 2017: 10/01/2017-09/30/2018 Column (D) 2016: 01/01/2017-09/30/2017 (Short Period) Column (C) 2015: 01/01/2016-12/31/2016 Column (B) 2014: 01/01/2015-12/31/2015 Column (A) 2013: 01/01/2014-12/31/2014 108695 75833 13214 7353 190389 62093 46076 10642 4658 5458 108695 62093 8904 8904 62093 62093 7353 7353 62093 62093 6500 6500 62093 0.00000 0.72440 0.27560 false false 0 0 X SCHEDULE D, PART V, LINE 4 TGEN FOUNDATION CLASSIFIES AS PERMANENTLY RESTRICTED NET ASSETS (1) THE ORIGINAL VALUE OF THE GIFT DONATED TO THE PERMANENT ENDOWMENT, (2) THE ORIGINAL VALUE OF SUBSEQUENT GIFTS DONATED TO THE PERMANENT ENDOWMENT, AND (3) ACCUMULATIONS TO THE PERMANENT ENDOWMENT MADE IN ACCORDANCE WITH THE DIRECTION OF THE APPLICABLE DONOR GIFT INSTRUMENT. TGEN FOUNDATION HAS A TEMPORARILY RESTRICTED ASSET WHICH HAS BEEN DESIGNED TO SUPPORT A SUMMER INTERN EACH YEAR AT TGEN. TGEN FOUNDATION'S POLICY FOR APPROPRIATING THE DISTRIBUTION OF ITS SUMMER INTERNSHIP PROGRAM ENDOWMENT HAS BEEN DESIGNED TO SUPPORT A GRANT TO TGEN FOR AN INTERN EACH YEAR FOR 20 YEARS. THE FOUNDATION CONSIDERED THE LONG-TERM EXPECTED RETURN ON ITS ENDOWMENT. TGEN FOUNDATION HAS A RESTRICTED ASSET WHICH ALLOWS THEM TO USE ANY INVESTMENT INCOME FOR OPERATING EXPENSES. SCHEDULE D, PART X, LINE 2 TGEN AND THE FOUNDATION ARE EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE. TGEN AND THE FOUNDATION ARE EXEMPT FROM ARIZONA CORPORATE INCOME TAX UNDER SECTION 43-1201(A) OF THE ARIZONA REVISED STATUTES (A.R.S.) ACCORDINGLY, NO PROVISION FOR INCOME TAX IS INCLUDED IN THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS. TGEN AND THE FOUNDATION HAVE NO SIGNIFICANT UNCERTAIN TAX POSITIONS OR TAX LIABILITY FOR TAX BENEFITS, INTEREST, OR PENALTIES ACCRUED AT SEPTEMBER 30, 2018. true TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 445 N 5TH STREET SUITE 600 Phoenix AZ 85004 753065445 501(c)(3) 5924869 0 FUNDRAISING FOR TGEN 1 0 SCHEDULE I, PART I, LINE 2 THE FOUNDATION IS ORGANIZED EXCLUSIVELY TO BENEFIT TGEN, A RELATED 501(C)(3) TAX-EXEMPT ORGANIZATION, BY SUPPORTING TGEN'S FUNDRAISING AND DEVELOPMENT FUNCTIONS. THE FOUNDATION RELIES UPON THE GOVERNANCE PRACTICES OF TGEN TO MONITOR USE OF GRANT FUNDS. false false false false false false false true false Michael Bassoff Pres., Tgen Fdn (thru 4/30/18) 0 467909 0 45583 0 17804 0 0 0 10306 0 541602 0 0 Teresa Burleson Board Member/ASST SEC/ASST TRE 0 436926 0 88520 0 1242 0 12500 0 8874 0 548062 0 0 Jeffry M Trent PhD Board Member 0 792452 0 140000 0 86946 0 21912 0 28474 0 1069784 0 0 Manuel Estrada Chief Financial Officer 0 253512 0 65739 0 810 0 0 0 10980 0 331041 0 0 Schedule J, Part I, Line 1a FIRST CLASS TRAVEL IS PERMITTED BY EXECUTIVE STAFF ONLY AND MUST BE PRE-APPROVED BY THE CHIEF OPERATING OFFICER. THESE EXPENSES WERE NOT CONSIDERED AS TAXABLE COMPENSATION TO THE RECIPIENT SINCE THEY WERE REIMBURSEMENTS FOR BUSINESS USE UNDER AN ACCOUNTABLE PLAN. TGEN, A RELATED TAX-EXEMPT ORGANIZATION, PROVIDES THIS BENEFIT. Schedule J, Part I, Line 3 TGEN FOUNDATION DOES NOT DETERMINE OR PAY ANY COMPENSATION OR BENEFITS. ALL COMPENSATION AND BENEFITS ARE DETERMINED AND PAID BY TGEN, A RELATED TAX-EXEMPT ORGANIZATION. Schedule J, Part I, Line 7 SOME OF TGENS OFFICERS, KEY EMPLOYEES AND 5-HIGHEST PAID INDIVIDUALS LISTED IN FORM 990, PART VII, WERE PAID BONUSES WHICH WERE BASED ON ACCOMPLISHMENTS OF SPECIFIC MILESTONES AND/OR PERFORMANCE METRICS, AS APPROVED BY THE TGEN BOARD OF DIRECTORS. FORM 990, PART III, LINE 4A THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION RAISES FUNDS FOR THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE ("TGEN"). THE PROGRAM SERVICE ACCOMPLISHMENTS OF TGEN ARE LISTED BELOW: TGEN SUMMARY OF 2018 ACTIVITIES TGEN PRODUCES SIGNIFICANT SCIENTIFIC AND MEDICAL PROGRESS ACROSS MULTIPLE AREAS THROUGH OUR CAPACITY TO UNDERSTAND AND LEVERAGE INFORMATION FROM THE GENOME. WITH THE AFFILIATION WITH CITY OF HOPE NEARING OUR SECOND FULL YEAR, TGEN AND CITY OF HOPE TOGETHER CONTINUE TO GROW AS NATIONAL AND INTERNATIONAL LEADERS IN THE TREATMENT OF DISEASE AND STRIVING TO QUICKLY BRING MEDICAL BENEFIT TO OUR PATIENTS. TGENS CLINICAL RESEARCH AND CLINICAL TRIAL PROJECTS WITH CITY OF HOPE EXTEND ACROSS A NUMBER OF AREAS AND CANCER TYPES, INCLUDING TREATMENT OF A VARIETY OF CANCER TYPES AND TUMORS WITH NEW CHEMICAL AGENTS, MICROBIOME CANCER ANALYSIS, HOSPITAL EPIDEMIOLOGY, METAGENOMICS, AND THE INCORPORATION OF MODERN TOOLS TO IDENTIFY PATIENTS GENOMIC CHARACTERISTICS THAT COULD LEAD TO A MORE TARGETED APPROACH. FURTHER, TGEN ESTABLISHED A CLINICAL MICROBIOME SERVICES CENTER, WHICH WILL WORK HAND-IN-HAND WITH RESEARCHERS AND PHYSICIANS AT TGEN AND CITY OF HOPE. TGENS PARTNERSHIPS HAVE RESULTED IN: A MULTI-YEAR, MULTI-MILLION DOLLAR EFFORT FUNDED BY THE NATIONAL CANCER INSTITUTE TO DEVELOP METHODS OF EARLY DETECTION IN PANCREATIC CANCER; AND ACCESS IN THE GULF SOUTH REGION TO THE LATEST CANCER THERAPEUTICS, RESEARCH, AND ADVANCED DIAGNOSTICS THROUGH A BROAD PORTFOLIO OF PHASE 1 AND 2 TRIALS. CLINICIANS AND SCIENTISTS IN TGENS CENTER FOR RARE CHILDHOOD DISORDERS CONTINUED USE OF PRECISION MEDICINE TO SEARCH FOR ANSWERS FOR YOUNG PATIENTS ON DIAGNOSTIC ODYSSEYS, WHO PRESENT WITH COMPLEX SYMPTOMS AND NO CLEAR DIAGNOSIS. ADDITIONALLY, TGEN INVESTIGATORS WERE AWARDED GRANTS IN MULTIPLE FIELDS, INCLUDING NEUROGENOMICS, CANCER THERAPEUTICS AND TREATMENTS, AND DISEASE DETECTION AND MONITORING. TGEN ADVANCED A SERIES OF INNOVATIVE RESEARCH INITIATIVES THAT YIELDED NUMEROUS SCIENTIFIC DISCOVERIES (MANY WITH POTENTIAL CLINICAL APPLICATION), ESTABLISHED NATIONAL AND INTERNATIONAL COLLABORATIONS, AND LED NEW AND EXCITING CLINICAL TRIALS WITH PROMISING RESULTS IN THE AREAS OF PATHOGENIC DISEASE, CANCER DIAGNOSIS AND MONITORING, NEUROGENOMICS, AND CANINE CANCER. SPECIFICALLY, TGEN INVESTIGATORS ARE PERFECTING NEW DETECTION AND SURVEILLANCE TECHNOLOGIES TO FIGHT PATHOGENIC OUTBREAKS, DEVELOPING LIQUID BIOPSY TECHNIQUES FOR NON-INVASIVE MONITORING AND EARLY DETECTION OF DISEASE, STUDYING GENETIC VARIANTS ASSOCIATED WITH BRAIN TUMORS AND MEMORY CAPACITY, CHARACTERIZING MOLECULAR CHANGES IN MUSCLE TISSUE THROUGH EXERCISE, AND ESTABLISHED THE GENETIC BASIS OF MELANOMA IN CANINES. TGEN INVESTIGATORS PUBLISHED THEIR RESEARCH RESULTS EXTENSIVELY IN SCHOLARLY PEER-REVIEWED ACADEMIC JOURNALS AND PRESENTED AT LEADING NATIONAL AND INTERNATIONAL CONFERENCES; INCLUDING PUBLICATION IN LEADING SCIENTIFIC JOURNALS SUCH AS AMERICAN JOURNAL OF HUMAN GENETICS, CELL, NATURE COMMUNICATIONS, JOURNAL OF NEUROSCIENCE, CLINICAL CANCER RESEARCH, CLINICAL INFECTIOUS DISEASE, JAMA NEUROLOGY, LANCET, MBIO, NEUROLOGY, NEW ENGLAND JOURNAL OF MEDICINE, AND SCIENCE TRANSLATIONAL MEDICINE, AND PRESENTATIONS AT LEADING CONFERENCES SUCH AS AACR. TGEN INVESTIGATORS FURTHER SERVE AS RESOURCES TO MEDICAL AND SCIENTIFIC RESEARCH CENTERS THROUGHOUT THE COUNTRY IN THEIR AREAS OF RESEARCH. IN EDUCATION AND OUTREACH, TGEN PROVIDED INTERNSHIPS TO STUDENTS WHO CONDUCTED RESEARCH PROJECTS IN TGEN LABS ON TOPICS INCLUDING NEUROLOGICAL DISEASE, CANCER, INFECTIOUS DISEASE, SEQUENCING, BIOINFORMATICS, AND RESEARCH ADMINISTRATION. ADDITIONALLY, TGEN PROVIDED A BIOSCIENCE LEADERSHIP ACADEMY FOR STUDENTS WHERE THEY LEARNED ABOUT A VARIETY OF TOPICS WITHIN THE THEMES OF PROFESSIONAL DEVELOPMENT, LEADERSHIP, TRANSLATIONAL MEDICINE, AND HOT TOPICS IN THE BIOSCIENCES. FORM 990, PART V, LINE 2A; PART VII, SECTION A; AND PART IX TGEN FOUNDATION DOES NOT HAVE EMPLOYEES, BUT SHARES THE COST OF PERSONNEL, SERVICES, FACILITIES AND EXPENSES WITH TGEN, A RELATED TAX-EXEMPT ORGANIZATION. FORM 990, PART VI, LINE 2 MICHAeL KAPLAN AND BENNETT DORRANCE HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, LINE 6 THE SOLE CORPORATE MEMBER OF TGEN FOUNDATION IS THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (TGEN). FORM 990, PART VI, LINE 7A TGEN, AS THE SOLE CORPORATE MEMBER OF TGEN FOUNDATION, HAS THE RIGHT TO ELECT THE BOARD OF DIRECTORS OF TGEN FOUNDATION. FORM 990, PART VI, LINE 7B THE SOLE CORPORATE MEMBER'S VOTE SHALL BE REQUIRED ON: (A) THE ELECTION AND REMOVAL OF ELECTED DIRECTORS AS SET FORTH IN THE BYLAWS; (B) THE ADOPTION OF ANY PLAN OF MERGER OR CONSOLIDATION; (C) THE SALE OF ALL OR SUBSTANTIALLY ALL THE FOUNDATION'S ASSETS IN A SINGLE TRANSACTION OR SERIES OF RELATED TRANSACTIONS; (D) THE AMENDMENT OF THE FOUNDATION'S ARTICLES OF INCORPORATION OR BYLAWS; (E) THE INSTITUTION, OR CONSENT TO INSTITUTION, OF PROCEEDINGS TO ADJUDICATE THE FOUNDATION BANKRUPT OR INSOLVENT, OR THE FILING OF A PETITION SEEKING OR CONSENTING TO REORGANIZATION OR RELIEF UNDER ANY LAW RELATING TO BANKRUPTCY, INSOLVENCY, OR OTHER RELIEF FOR DEBTORS, OR THE CONSENT TO THE APPOINTMENT OF A RECEIVER, LIQUIDATOR, ASSIGNEE, TRUSTEE, SEQUESTRATOR (OR SIMILAR OFFICIAL) OF THE FOUNDATION OR OF ALL OR ANY SUBSTANTIAL PART OF ITS PROPERTY, OR THE MAKING OF ANY ASSIGNMENT FOR THE BENEFIT OF CREDITORS, OR THE ADMISSION IN WRITING OF THE FOUNDATION'S INABILITY TO PAY ITS DEBTS GENERALLY AS THEY BECOME DUE, OR ANY STEPS IN FURTHERANCE OF SUCH ACTIONS; AND (F) THOSE MATTERS UPON WHICH THE MEMBER IS GRANTED VOTING RIGHTS IN THE ARTICLES OF INCORPORATION, BYLAWS, OR THE ARIZONA NONPROFIT CORPORATION ACT. THE SOLE CORPORATE MEMBER HAS THE FOLLOWING RESERVE POWERS: (A) APPOINT AND REMOVE THE PRESIDENT; (B) APPROVE THE ESTABLISHMENT OF NEW CORPORATE PARTNERSHIP ENTITIES CREATED OR JOINED BY THE FOUNDATION; (C) APPROVE THE FOUNDATION'S EXECUTION OF MATERIAL CONTRACTS; AND (D) APPROVE THE FOUNDATION'S INCURRENCE OF MATERIAL DEBTS. FORM 990, PART VI, LINE 11B THE FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM BASED ON INFORMATION PROVIDED BY THE TGEN FINANCE DEPARTMENT. THE FORM 990 IS THEN REVIEWED BY THE FINANCE DEPARTMENT, OTHER MEMBERS OF MANAGEMENT AND THE AUDIT AND COMPLIANCE COMMITTEE OF THE CITY OF HOPE. THE FORM 990 IS POSTED ON THE BOARD WEBSITE FOR BOARD REVIEW PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, LINE 12C TGEN FOUNDATION DISTRIBUTES A CONFLICT OF INTEREST QUESTIONNAIRE ANNUALLY TO DIRECTORS, OFFICERS AND COVERED EMPLOYEES (DIRECTOR LEVEL AND ABOVE). IN ADDITION TO ANY OFFICERS AND KEY EMPLOYEES DESIGNATED BY THE CHIEF OPERATING OFFICER. THE QUESTIONNAIRES ARE REVIEWED BY THE CHIEF FINANCIAL OFFICER AND TGEN'S OFFICE OF RESEARCH COMPLIANCE, AND IF APPLICABLE THE BOARD OR A COMMITTEE OF THE BOARD. THOSE EMPLOYEES WITH CONFLICTS ARE SENT FOR FURTHER REVIEW TO THE CHIEF OPERATING OFFICER TO DETERMINE WHETHER THE CONFLICT MAY BE MANAGED UNDER AN APPROPRIATE MANAGEMENT PLAN AND IF SO, A MANAGEMENT PLAN MAY BE PUT IN PLACE TO MANAGE THE CONFLICTS. FORM 990, PART VI, LINES 15A AND 15B THE FOUNDATION DOES NOT HAVE ANY DIRECT EMPLOYEES. COMPENSATION IS DETERMINED BY THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (TGEN) USING THE FOLLOWING PROCESS: THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF THE MEMBER SHALL BE THE EXECUTIVE COMPENSATION COMMITTEE OF TGEN. NOTWITHSTANDING THE FOREGOING, TGEN'S GOVERNANCE AND EXECUTIVE COMPENSATION COMMITTEE WILL ACT IN AN "ADVISE AND CONSENT" CAPACITY REVIEWING THE RECOMMENDATIONS OF THE PRESIDENT AND SCIENTIFIC DIRECTOR REGARDING THE COMPENSATION OF DISQUALIFIED PERSONS CONSISTENT WITH THE MEMBER'S COMPENSATION PHILOSOPHY AND WITHIN THE COMPENSATION RANGES APPROVED AT LEAST ANNUALLY BY THE MEMBER, AND FORWARDING FINAL RECOMMENDATIONS TO THE FULL TGEN BOARD FOR APPROVAL. DISQUALIFIED PERSONS (EXCEPT FOR THE PRESIDENT AND SCIENTIFIC DIRECTOR) WILL NOT BE PRESENT FOR, OR PARTICIPATE IN, COMMITTEE DELIBERATIONS CONCERNING THEIR COMPENSATION (OTHER THAN TO ANSWER QUESTIONS). THE PRESIDENT AND SCIENTIFIC DIRECTOR WILL PARTICIPATE IN THE DELIBERATIONS CONCERNING THE COMPENSATION OF DIRECT REPORTS. DURING THE DECISION MAKING PROCESS, THE COMMITTEE WILL ADHERE TO THE EXECUTIVE COMPENSATION PHILOSOPHY OF THE MEMBER. THE COMMITTEE IS AUTHORIZED (AND PROVIDED WITH SUFFICIENT FUNDING) TO ANNUALLY ENGAGE OUTSIDE INDEPENDENT COMPENSATION AND LEGAL ADVISORS, WHEN DEEMED NECESSARY AND ADVISABLE. THE COMMITTEE WILL COMPLY WITH THE "REBUTTABLE PRESUMPTION OF REASONABLENESS" UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE WHENEVER POSSIBLE. THE COMMITTEE WILL REVIEW AND UNDERSTAND THE INTERNAL REVENUE CODE PROVISIONS DEALING WITH "EXCESS BENEFIT TRANSACTIONS CONCERNING DISQUALIFIED PERSONS' COMPENSATION." WHEN DEVELOPING A COMPENSATION PHILOSOPHY, TGEN KEPT IN MIND THE FOLLOWING FACTORS: -THE TGEN MISSION AND STRATEGY -THE TGEN CULTURE -TRENDS IN COMPENSATION IN THE EXTERNAL ENVIRONMENT -TRENDS IN RECRUITMENT OF NEW EMPLOYEES -TRENDS IN ORGANIZATIONAL EMPLOYEE TURNOVER -TGEN'S LIFE CYCLE STAGE THE COMPENSATION REVIEW PROCESS WAS LAST COMPLETED IN 2018. FORM 990, PART VI, LINE 19 TGEN FOUNDATION PROVIDES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY TO THE GENERAL PUBLIC UPON REQUEST. THE TRANSLATIONAL GENOMICS RESEARCH INST 445 N 5TH STREET SUITE 600 PHOENIX AZ 85004 753065445 RESEARCH AZ 501(c)(3) 7 NA false CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 FUNDRAISING CA 501(c)(3) 7 NA false CITY OF HOPE NATIONAL MEDICAL CENTER 1500 EAST DUARTE ROAD DUARTE CA 91010 951683875 HOSPITAL CA 501(c)(3) 3 CITY OF HOPE true BECKMAN RESEARCH INSTITUTE 1450 EAST DUARTE ROAD DUARTE CA 91010 953432210 RESEARCH CA 501(c)(3) 4 CITY OF HOPE true CITY OF HOPE MEDICAL FOUNDATION 1500 EAST DUARTE ROAD DUARTE CA 91010 274803222 HEALTHCARE CA 501(c)(3) 3 CITY OF HOPE true false true false false false false false false false false false true false true true false false false false